Abstract

Constipation is a common problem in males and females. The aim of the present study was to evaluate the laxative effects of fermented rice extract (FRe) on rats with loperamide-induced constipation. FRe (100, 200 and 300 mg/kg) was administered orally once per day for six days following 1 h loperamide treatment. The laxative effects of FRe were compared with those of sodium picosulfate (S. picosulfate). Following the induction of constipation in the rats, a marked decrease was observed in the fecal pellet number and water content discharged over 24 h, the surface mucus thickness in the colonic lumen, intestinal charcoal transit ratio, thickness of the colonic mucosa and the number of mucus-producing cells, while an increase was observed in the number of fecal pellets remaining in the colonic lumen and their mean diameter, as compared with the normal vehicle control rats. These conditions were significantly alleviated following the administration of the three doses of FRe when compared with the loperamide control group. However, the alleviating effects were lower than those of S. picosulfate, with the exception of the intestinal charcoal transit ratio. Similar effects on the intestinal charcoal transit ratio were detected for the three doses of FRe when compared with the S. picosulfate-treated rats. In conclusion, the results indicated that FRe exhibits a laxative effect without causing diarrhea, as compared with sodium picosulfate; thus, FRe may be effective as a complementary medicine in patients suffering from lifestyle-induced constipation.

Highlights

  • Constipation is a common health problem with a tendency to cause discomfort and affect patient quality of life [1]

  • No significant change in body weight was detected when comparing any of the fermented rice extract (FRe)‐treated groups with the vehicle and loperamide control groups (Table I)

  • Statistically significant (P

Read more

Summary

Introduction

Constipation is a common health problem with a tendency to cause discomfort and affect patient quality of life [1]. This highly prevalent functional gastrointestinal disorder affects 3‐15% of the general population [2,3]. Drugs that contain magnesium oxide or sennoside, the main constituent of Senna, are frequently administered for the treatment of constipation due to their powerful purgative/laxative effects. These drugs induce severe diarrhea as a side‐effect [1]. Repeated use of Senna or other anthraquinone‐containing drugs may induce melanosis coli, which is a risk factor for colorectal neoplasia [6]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call